Uri Yablonka - Net Worth and Insider Trading
Uri Yablonka Net Worth
The estimated net worth of Uri Yablonka is at least $604 dollars as of 2024-11-13. Uri Yablonka is the EVP & Chief Business Officer of Brainstorm Cell Therapeutics Inc and owns about 503 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $604. Details can be seen in Uri Yablonka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Uri Yablonka has not made any transactions after 2017-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Uri Yablonka
Uri Yablonka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Uri Yablonka owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Uri Yablonka’s form 4 insider trades.
Insider Ownership Summary of Uri Yablonka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-12 | director & EVP and Chief Business Officer |
Uri Yablonka Latest Holdings Summary
Uri Yablonka currently owns a total of 1 stock. Uri Yablonka owns 503 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of August 23, 2017, with a value of $604.
Latest Holdings of Uri Yablonka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2017-08-23 | 503 | 1.20 | 604 |
Holding Weightings of Uri Yablonka
Uri Yablonka Form 4 Trading Tracker
According to the SEC Form 4 filings, Uri Yablonka has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 133 shares on August 23, 2017, which cost Uri Yablonka around $7,960.
Insider Trading History of Uri Yablonka
- 1
Uri Yablonka Trading Performance
GuruFocus tracks the stock performance after each of Uri Yablonka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Uri Yablonka is -2.2%. GuruFocus also compares Uri Yablonka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Uri Yablonka within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Uri Yablonka's insider trading performs compared to the benchmark.
Performance of Uri Yablonka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.24 |  | | | | |
| Relative Return to S&P 500(%) | -1.55 | | | | | |
Uri Yablonka Ownership Network
Ownership Network List of Uri Yablonka
Ownership Network Relation of Uri Yablonka
Uri Yablonka Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Uri Yablonka is the director & EVP and Chief Business Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Uri Yablonka made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Uri Yablonka Mailing Address
Above is the net worth, insider trading, and ownership report for Uri Yablonka. You might contact Uri Yablonka via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 605 Third Avenue, 34th Floor, New York Ny 10158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
